GSA CAPITAL PARTNERS LLP

Position in ILMN — Illumina, Inc.

CIK 1362033 LONDON, X0

Position in ILMN

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$260,931

-$222,846 QoQ

Shares Held

1,484

-70.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#665

of 932 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. ILMN ranks #15 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	11,336	$3,077,157
2	TMO	Thermo Fisher Scientific Inc.	4,702	$2,357,394
3	GH	Guardant Health, Inc.	11,811	$1,772,004
4	BDSX	Biodesix Inc	46,989	$1,059,601
5	DGX	Quest Diagnostics Inc	4,971	$1,053,603
6	IDXX	Idexx Laboratories Inc /De	1,981	$1,042,877
7	XGN	Exagen Inc.	214,721	$998,452
8	MTD	Mettler Toledo International Inc/	619	$790,778

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$260,931	1,484	-70.9%	Shares	Sole	2026-08-06
2025-09-30	$483,777	5,094	-7.3%	Shares	Sole	2025-11-07
2025-06-30	$524,182	5,494	-22.7%	Shares	Sole	2025-07-22
2025-03-31	$563,552	7,103	+73.3%	Shares	Sole	2025-05-08
2024-12-31	$547,749	4,099	+52.4%	Shares	Sole	2025-02-07
2024-09-30	$350,802	2,690	-53.2%	Shares	Sole	2024-11-05
2024-06-30	$600,498	5,753	+22.5%	Shares	Sole	2024-08-15
2024-03-31	$645,129	4,698	+188.4%	Shares	Sole	2024-05-03
2023-03-31	$378,824	1,629	+145.0%	Shares	Sole	2023-05-12
2021-12-31	$252,992	665	-7.5%	Shares	Sole	2022-02-14
2021-06-30	$340,237	719	+12.5%	Shares	Sole	2021-08-05
2021-03-31	$245,414	639	-67.2%	Shares	Sole	2021-05-10
2020-09-30	$601,469	1,946	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.